17-41227027-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031961.3(KRTAP9-2):c.373A>G(p.Thr125Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000348 in 1,611,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T125S) has been classified as Uncertain significance.
Frequency
Consequence
NM_031961.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 4AN: 149196Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251486 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461848Hom.: 0 Cov.: 207 AF XY: 0.0000344 AC XY: 25AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000268 AC: 4AN: 149196Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 2AN XY: 72640 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.373A>G (p.T125A) alteration is located in exon 1 (coding exon 1) of the KRTAP9-2 gene. This alteration results from a A to G substitution at nucleotide position 373, causing the threonine (T) at amino acid position 125 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at